Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab

Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab

BACKGROUND: Src, CDKN1B, and JAK2 play a crucial role in the coordination of cell signaling pathways. In the present study, we aim to investigate the prognostic significance of these biomarkers in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab (T). METHODS: Formalin-f...

Full description

Bibliographic Details
Main Authors: Panagiota Economopoulou, Vassiliki Kotoula, Georgia-Angeliki Koliou, Kyriaki Papadopoulou, Christos Christodoulou, George Pentheroudakis, Georgios Lazaridis, Petroula Arapantoni-Dadioti, Angelos Koutras, Dimitris Bafaloukos, Pavlos Papakostas, Helen Patsea, Kitty Pavlakis, Dimitrios Pectasides, Athanasios Kotsakis, Evangelia Razis, Gerasimos Aravantinos, Epaminondas Samantas, Konstantine T. Kalogeras, Theofanis Economopoulos, Amanta Psyrri, George Fountzilas
Format: Article
Language:English
Published: Elsevier 2019-05-01
Series:Translational Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523318306211

Internet

http://www.sciencedirect.com/science/article/pii/S1936523318306211

Similar Items